215 related articles for article (PubMed ID: 11440964)
1. Role of genetic polymorphism of glutathione-S-transferase T1 and microsomal epoxide hydrolase in aflatoxin-associated hepatocellular carcinoma.
Tiemersma EW; Omer RE; Bunschoten A; van't Veer P; Kok FJ; Idris MO; Kadaru AM; Fedail SS; Kampman E
Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):785-91. PubMed ID: 11440964
[TBL] [Abstract][Full Text] [Related]
2. A systematic approach to analysing gene-gene interactions: polymorphisms at the microsomal epoxide hydrolase EPHX and glutathione S-transferase GSTM1, GSTT1, and GSTP1 loci and breast cancer risk.
Spurdle AB; Chang JH; Byrnes GB; Chen X; Dite GS; McCredie MR; Giles GG; Southey MC; Chenevix-Trench G; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):769-74. PubMed ID: 17416769
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma and polymorphisms in carcinogen-metabolizing and DNA repair enzymes in a population with aflatoxin exposure and hepatitis B virus endemicity.
Kirk GD; Turner PC; Gong Y; Lesi OA; Mendy M; Goedert JJ; Hall AJ; Whittle H; Hainaut P; Montesano R; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Feb; 14(2):373-9. PubMed ID: 15734960
[TBL] [Abstract][Full Text] [Related]
4. Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: a study in the Spanish population.
Ladero JM; Martínez C; García-Martín E; Ropero P; Briceño O; Villegas A; Díaz-Rubio M; Agúndez JA
Eur J Cancer; 2006 Jan; 42(1):73-7. PubMed ID: 16314088
[TBL] [Abstract][Full Text] [Related]
5. Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathione S-transferases M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk.
Brockmöller J; Cascorbi I; Kerb R; Roots I
Cancer Res; 1996 Sep; 56(17):3915-25. PubMed ID: 8752158
[TBL] [Abstract][Full Text] [Related]
6. Influence of glutathione-S-transferase theta (GSTT1) and micro (GSTM1) gene polymorphisms on the susceptibility of hepatocellular carcinoma in Taiwan.
Kao CC; Chen MK; Kuo WH; Chen TY; Su SC; Hsieh YH; Liu CL; Chou MC; Tsai HT; Yang SF
J Surg Oncol; 2010 Sep; 102(4):301-7. PubMed ID: 20672314
[TBL] [Abstract][Full Text] [Related]
7. Molecular and genetic epidemiology of hepatocellular carcinoma: studies in China and Senegal.
London WT; Evans AA; Buetow K; Litwin S; McGlynn K; Zhou T; Clapper M; Ross E; Wild C; Shen FM
Princess Takamatsu Symp; 1995; 25():51-60. PubMed ID: 8875609
[TBL] [Abstract][Full Text] [Related]
8. Glutathione-S-transferase and microsomal epoxide hydrolase polymorphism and viral-related hepatocellular carcinoma risk in India.
Kiran M; Chawla YK; Kaur J
DNA Cell Biol; 2008 Dec; 27(12):687-94. PubMed ID: 18816171
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms of microsomal epoxide hydroxylase and glutathione S-transferases M1, T1 and P1, interactions with smoking, and risk for esophageal (Barrett) adenocarcinoma.
Casson AG; Zheng Z; Porter GA; Guernsey DL
Cancer Detect Prev; 2006; 30(5):423-31. PubMed ID: 17064856
[TBL] [Abstract][Full Text] [Related]
10. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans.
McGlynn KA; Hunter K; LeVoyer T; Roush J; Wise P; Michielli RA; Shen FM; Evans AA; London WT; Buetow KH
Cancer Res; 2003 Aug; 63(15):4594-601. PubMed ID: 12907637
[TBL] [Abstract][Full Text] [Related]
11. SNPs of GSTM1, T1, P1, epoxide hydrolase and DNA repair enzyme XRCC1 and risk of urinary transitional cell carcinoma in southwestern Taiwan.
Hsu LI; Chiu AW; Huan SK; Chen CL; Wang YH; Hsieh FI; Chou WL; Wang LH; Chen CJ
Toxicol Appl Pharmacol; 2008 Apr; 228(2):144-55. PubMed ID: 18199464
[TBL] [Abstract][Full Text] [Related]
12. Determinants of the variability of aflatoxin-albumin adduct levels in Ghanaians.
Dash B; Afriyie-Gyawu E; Huebner HJ; Porter W; Wang JS; Jolly PE; Phillips TD
J Toxicol Environ Health A; 2007 Jan; 70(1):58-66. PubMed ID: 17162498
[TBL] [Abstract][Full Text] [Related]
13. Alcohol dehydrogenase 3, glutathione S-transferase M1 and T1 polymorphisms, alcohol consumption and hepatocellular carcinoma (Italy).
Covolo L; Gelatti U; Talamini R; Garte S; Trevisi P; Franceschi S; Franceschini M; Barbone F; Tagger A; Ribero ML; Parrinello G; Donadon V; Nardi G; Donato F
Cancer Causes Control; 2005 Sep; 16(7):831-8. PubMed ID: 16132793
[TBL] [Abstract][Full Text] [Related]
14. Combined analysis of polymorphisms in glutathione S-transferase M1 and microsomal epoxide hydrolase in lung cancer patients.
Habalová V; Salagovic J; Kalina I; Stubna J
Neoplasma; 2004; 51(5):352-7. PubMed ID: 15640939
[TBL] [Abstract][Full Text] [Related]
15. The Tyr113His polymorphism in exon 3 of the microsomal epoxide hydrolase gene is a risk factor for perinatal mortality.
Raijmakers MT; de Galan-Roosen TE; Schilders GW; Merkus JM; Steegers EA; Peters WH
Acta Obstet Gynecol Scand; 2004 Nov; 83(11):1056-60. PubMed ID: 15488121
[TBL] [Abstract][Full Text] [Related]
16. Association between lung cancer and microsomal epoxide hydrolase genotypes.
Benhamou S; Reinikainen M; Bouchardy C; Dayer P; Hirvonen A
Cancer Res; 1998 Dec; 58(23):5291-3. PubMed ID: 9850050
[TBL] [Abstract][Full Text] [Related]
17. Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer.
Lancaster JM; Brownlee HA; Bell DA; Futreal PA; Marks JR; Berchuck A; Wiseman RW; Taylor JA
Mol Carcinog; 1996 Nov; 17(3):160-2. PubMed ID: 8944076
[TBL] [Abstract][Full Text] [Related]
18. Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
Singh M; Shah PP; Singh AP; Ruwali M; Mathur N; Pant MC; Parmar D
Mutat Res; 2008 Feb; 638(1-2):184-94. PubMed ID: 18035380
[TBL] [Abstract][Full Text] [Related]
19. [A study about the association of detoxication gene GSTM1 polymorphism and the susceptibility to aflatoxin B1-related hepatocellular carcinoma].
Long XD; Ma Y; Wei YP; Deng ZL
Zhonghua Gan Zang Bing Za Zhi; 2005 Sep; 13(9):668-70. PubMed ID: 16174455
[TBL] [Abstract][Full Text] [Related]
20. GSTM1, GSTT1, and GSTP1 polymorphism and lung cancer risk in relation to tobacco smoking.
Schneider J; Bernges U; Philipp M; Woitowitz HJ
Cancer Lett; 2004 May; 208(1):65-74. PubMed ID: 15105047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
